Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-04 9:40 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 200,000 | $13.44 | $2,688,751 | 368,852 (Direct) | View |
| 2023-09-01 Sale | 2023-09-05 8:04 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $7.7052 | $770,520 | 265,581 (Direct) | View |
| 2023-08-03 Sale | 2023-08-07 5:05 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 45,004 | $7.0325 | $316,489 | 235,237 (Direct) | View |
| 2023-08-01 Sale | 2023-08-03 6:03 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $7.1249 | $391,841 | 342,629 (Direct) | View |
| 2023-07-07 Sale | 2023-07-07 8:16 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $6.364 | $56,372 | 313,343 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 8:55 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $6.4784 | $590,453 | 644,043 (Direct) | View |
| 2023-06-01 Sale | 2023-06-02 7:48 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $6.8404 | $684,041 | 643,281 (Direct) | View |
| 2022-11-09 Sale | 2023-05-10 4:53 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 143,896 | $5.4246 | $780,579 | 859,240 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 200,000 | $0 | 368,852 (Direct) | View |
| 2024-12-03 Exercise | 2024-12-04 9:40 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 77,150 | $3.15 | 368,852 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-04 9:40 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 122,850 | $1.27 | 368,852 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:00 pm | N/A 2034-06-19 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 8:05 pm | N/A 2034-06-02 | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 102,225 | $0 | 102,225 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-05 8:04 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $0 | 265,581 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-05 8:04 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $1.27 | 265,581 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 5:05 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 44,914 | $0 | 235,237 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 5:05 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 45,004 | $1.27 | 235,237 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 6:03 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $0 | 342,629 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 6:03 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 54,996 | $1.27 | 342,629 (Direct) | View |
| 2023-07-07 Exercise | 2023-07-07 8:16 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $0 | 313,343 (Direct) | View |
| 2023-07-07 Exercise | 2023-07-07 8:16 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 8,858 | $1.27 | 313,343 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:55 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $0 | 644,043 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:55 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 91,142 | $1.27 | 644,043 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-28 9:00 pm | N/A 2033-06-26 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 7:48 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $0 | 643,281 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 7:48 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $1.27 | 643,281 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-01 6:31 pm | N/A 2033-05-30 | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 66,055 | $0 | 66,055 (Direct) | View |
| 2023-05-24 Gift | 2023-05-26 4:14 pm | N/A N/A | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 12,099 | $0 | 40,000 (Direct) | View |
| 2023-05-08 Exercise | 2023-05-10 4:53 pm | N/A 2030-04-28 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $0 | 859,240 (Direct) | View |
| 2023-05-08 Exercise | 2023-05-10 4:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 100,000 | $1.27 | 859,240 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 4:38 pm | N/A 2030-04-28 | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 78,740 | $0 | 657,239 (Direct) | View |
| 2022-08-05 Exercise | 2022-08-09 4:38 pm | N/A N/A | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 78,740 | $1.27 | 657,239 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:10 pm | N/A 2032-06-07 | Nkarta Inc. | NKTX | Shawver Laura Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-05-27 Option Award | 2022-05-27 5:35 pm | N/A 2032-05-26 | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 41,597 | $0 | 41,597 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 5:19 pm | N/A 2032-05-01 | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 204,321 | $0 | 311,716 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-02 5:17 pm | N/A 2032-01-31 | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 297,000 | $0 | 376,895 (Direct) | View |
| 2021-06-13 Option Award | 2021-06-15 10:25 am | N/A 2031-06-12 | Nkarta Inc. | NKTX | Shawver Laura Director | 16,511 | $0 | 16,511 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 7:46 pm | N/A 2031-05-18 | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 7:59 pm | N/A 2030-12-02 | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 562,631 | $0 | 562,631 (Direct) | View |
Ownership | 2020-12-03 8:52 pm | N/A N/A | Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer | 0 | $0 | 1,002,995 (Direct) | View |
Ownership | 2020-07-15 8:18 pm | N/A N/A | Relay Therapeutics Inc. | RLAY | Shawver Laura Director | 0 | $0 | 73,219 (Direct) | View |
| 2020-07-09 Option Award | 2020-07-13 9:45 pm | N/A 2030-07-08 | Nkarta Inc. | NKTX | Shawver Laura Director | 29,000 | $0 | 29,000 (Direct) | View |
Ownership | 2020-07-09 8:50 pm | N/A 2030-03-26 | Nkarta Inc. | NKTX | Shawver Laura Director | 0 | $0 | 29,729 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:41 pm | N/A 2028-05-16 | Synthorx Inc. | THOR | Shawver Laura President and CEO | 293,177 | $67.07 | 0 (Direct) | View |
| 2020-01-08 Gift | 2020-01-24 6:41 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 80,706 | $0 | 0 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:41 pm | N/A 2027-12-06 | Synthorx Inc. | THOR | Shawver Laura President and CEO | 172,264 | $67.37 | 0 (Direct) | View |
| 2020-01-23 Disposition | 2020-01-24 6:41 pm | N/A 2028-12-05 | Synthorx Inc. | THOR | Shawver Laura President and CEO | 385,185 | $57 | 0 (Direct) | View |
| 2020-01-23 Equity Swap | 2020-01-24 6:41 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 245,595 | $68 | 0 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-02 4:39 pm | N/A 2028-05-16 | Synthorx Inc. | THOR | Shawver Laura President and CEO | 379,453 | $0 | 1,171,927 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-02 4:39 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 120,815 | $11 | 1,171,927 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-02 4:39 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 147,264 | $0.63 | 1,171,927 (Direct) | View |
| 2019-12-30 Tax Withholding | 2020-01-02 4:39 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 210,010 | $70.63 | 1,171,927 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-02 4:39 pm | N/A N/A | Synthorx Inc. | THOR | Shawver Laura President and CEO | 111,374 | $0.93 | 1,171,927 (Direct) | View |